|
Evaluation of imaging diagnostics in dizziness induced by cerebral small vessel disease: A focus on transcranial Doppler and CT
|
Y. Wei   , Q. Wang , J. Yang |
|
|
|
Abstract: (345 Views) |
Background: This study aims to evaluate the therapeutic efficacy of hyperbaric oxygen (HBO) as adjuvant therapy for patients with cerebral small vessel disease (CSVD) related dizziness and to assess the impact of this treatment on diagnostic indicators from both transcranial Doppler (TCD) and computed tomography (CT). Materials and Methods: A prospective randomized controlled study was conducted from January 2019 to December 2023, including 200 patients with CSVD related dizziness. They were randomly assigned to either the HBO group or the control group. The control group received betahistine mesylate tablets, while the HBO group received HBO in addition to the control group treatment. Various parameters including Dizziness Handicap Inventory (DHI) scores, cerebral artery blood flow velocity (Vm), resistance index (RI), pulsatility index (PI), cystatin (Cys), homocysteine (HCY), hypersensitive c-reactive protein (hs-CRP) levels, and CT imaging for grading cerebral white matter degeneration were assessed before and after treatment. Results: After treatment, DHI scores in both groups decreased significantly, with the HBO group showing greater improvement compared to the control group. Hemodynamic parameters (Vm, RI, PI) improved significantly in both groups, with greater improvements seen in the HBO group. White matter lesion grading and levels of Cys, HCY, and hs-CRP were significantly lower in the HBO group post-treatment compared to the control group. Conclusions: HBO as adjuvant therapy demonstrates significant therapeutic benefits for CSVD related dizziness. It effectively alleviates symptoms, improves hemodynamic parameters, enhances white matter lesion assessment outcomes, and promotes neurological function recovery. |
|
| Keywords: Cerebral small vessel disease, dizziness, transcranial Doppler, computed tomography, diagnostic imaging. |
|
|
Full-Text [PDF 1306 kb]
(110 Downloads)
|
|
Type of Study: Short Report |
Subject:
Radiation Biology
|
|
|
|
|
|
|
| References |
1. Litak J, Mazurek M, Kulesza B, et al. (2020) Cerebral Small Vessel Disease. International Journal of Molecular Sciences, 21(24): 9729. [ DOI:10.3390/ijms21249729] 2. Li Q, Yang Y, Reis C, et al. (2018) Cerebral Small Vessel Disease. Cell Transplantation, 27(12): 1711-1722. [ DOI:10.1177/0963689718795148] 3. van den Brink H, Doubal FN, Duering M (2023) Advanced MRI in cerebral small vessel disease. International Journal of Stroke, 18(1): 28-35. [ DOI:10.1177/17474930221091879] 4. Zanon ZM, Sveikata L, Viswanathan A, Yilmaz P (2021) Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Current Opinion in Neurology, 34(2): 246-257. [ DOI:10.1097/WCO.0000000000000913] 5. Liu Y, Dong YH, Lyu PY, Chen WH, Li R (2018) Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment. Chinese Medical Journal, 131(5): 615-619. [ DOI:10.4103/0366-6999.226069] 6. Benveniste H and Nedergaard M (2022) Cerebral small vessel disease: A glymphopathy? Current Opinion in Neurobiology, 72: 15-21. [ DOI:10.1016/j.conb.2021.07.006] 7. Chen X, Wang J, Shan Y, et al. (2019) Cerebral small vessel disease: neuroimaging markers and clinical implication. Journal of Neurology, 266(10): 2347-2362. [ DOI:10.1007/s00415-018-9077-3] 8. Bordes C, Sargurupremraj M, Mishra A, Debette S (2022) Genetics of common cerebral small vessel disease. Nature Reviews Neurology, 18(2): 84-101. [ DOI:10.1038/s41582-021-00592-8] 9. Low A, Mak E, Rowe JB, Markus HS, O'Brien JT (2019) Inflammation and cerebral small vessel disease: A systematic review. Ageing Research Reviews, 53: 100916. [ DOI:10.1016/j.arr.2019.100916] 10. Thrippleton MJ, Backes WH, Sourbron S, et al. (2019) Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. Alzheimers & Dementia, 15(6): 840-858. [ DOI:10.1016/j.jalz.2019.01.013] 11. Markus HS (2021) Cerebral small vessel disease: Microbleeds, perforator artery imaging and cliostozol. International Journal of Stroke, 16(9): 1000-1001. [ DOI:10.1177/17474930211062814] 12. Zwanenburg J and van Osch M (2017) targeting cerebral small vessel disease with MRI. Stroke, 48(11): 3175-3182. [ DOI:10.1161/STROKEAHA.117.016996] 13. Ter Telgte A, van Leijsen E, Wiegertjes K, Klijn C, Tuladhar AM, de Leeuw FE (2018) Cerebral small vessel disease: from a focal to a global perspective. Nature Reviews Neurology, 14(7): 387-398. [ DOI:10.1038/s41582-018-0014-y] 14. Blumen HM, Jayakody O, Verghese J (2023) Gait in cerebral small vessel disease, pre-dementia, and dementia: A systematic review. International Journal of Stroke, 18(1): 53-61. [ DOI:10.1177/17474930221114562] 15. Wang J, Wang B, Wang K (2023) Review of neuroimaging research progress of cerebral small vessel disease. Folia Neuropathologica, 61(1): 1-7. [ DOI:10.5114/fn.2023.124712] 16. Shi Y, Thrippleton MJ, Makin SD, et al. (2016) Cerebral blood flow in small vessel disease: A systematic review and meta-analysis. Journal of Cerebral Blood Flow and Metabolism, 36(10): 1653-1667. [ DOI:10.1177/0271678X16662891] 17. Mancuso M, Arnold M, Bersano A, et al. (2020) Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. European Journal of Neurology, 27(6): 909-927. [ DOI:10.1111/ene.14183] 18. Backhouse EV, Boardman JP, Wardlaw JM (2024) Cerebral small vessel disease: early-life antecedents and long-term implications for the brain, aging, stroke, and dementia. Hypertension, 81(1): 54-74. [ DOI:10.1161/HYPERTENSIONAHA.122.19940] 19. Pinter D, Enzinger C, Fazekas F (2015) Cerebral small vessel disease, cognitive reserve and cognitive dysfunction. Journal of Neurology, 262(11): 2411-2419. [ DOI:10.1007/s00415-015-7776-6] 20. Grochowski C, Litak J, Kamieniak P, Maciejewski R (2018) Oxidative stress in cerebral small vessel disease. Role of reactive species. Free Radical Research, 52(1): 1-13. [ DOI:10.1080/10715762.2017.1402304] 21. Hainsworth AH, Oommen AT, Bridges LR (2015) Endothelial cells and human cerebral small vessel disease. Brain Pathology, 25(1): 44-50. [ DOI:10.1111/bpa.12224] |
|
| Add your comments about this article |
|
|
|
|
Wei Y, Wang Q, Yang J. Evaluation of imaging diagnostics in dizziness induced by cerebral small vessel disease: A focus on transcranial Doppler and CT. Int J Radiat Res 2025; 23 (1) :249-254 URL: http://ijrr.com/article-1-6111-en.html
|
